ARCHIVES

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

AHCPR Invites Ideas for Outcomes Research

June 7, 1996

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

April 25, 2014

Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.

July 10, 2009

NCI brings in grantees to explain their work, promise of nanotech, to advisory board.

July 16, 2004

DCCP Board Okays Concepts Of New Grants Totaling $1.4 Million Year

February 18, 1983

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

January 4, 1991